Clinical Trials Directory

Trials / Completed

CompletedNCT01166945

Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
98 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
1 Year – 10 Years
Healthy volunteers
Not accepted

Summary

The investigators objective is to compare short course (5 days) to long course (14 days)antibiotics for the treatment of acute bacterial sinusitis in children. The investigators hypothesize that short course therapy will lead to more frequent relapses of sinusitis and will not reduce resistant organisms.

Detailed description

This was a prospective, randomized, double-blind study comparing short course (5 days) to long course (14 days) antimicrobial therapy for children between 1 and 10 years of age with acute bacterial sinusitis. The major outcome measure is the proportion of children with a clinical relapse on day 10 in the short course therapy group compared to day 20 in the long course therapy group. In addition, the proportion of respiratory flora that are resistant to antibiotics on day 30 will be compared to baseline in each group.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillin-Potassium Clavulanate CombinationAll subjects will be started on treatment with 5 days of high dose amoxicillin (90mg/kg) with potassium clavulanate (6.4 mg/kg) twice daily in bottle A. The allocation to group B1 or B2 will be concealed until after the family and subject has signed the assent and consent, respectively. The maximum dose will be 2 gms twice daily. After 5 days the subjects will be randomized to either continue to receive the same dose of amoxicillin clavulanate or a look-a-like and taste-a-like placebo for the next 9 days.
DRUGPlaceboAfter 5 days the subjects will be randomized to either continue to receive the same dose of amoxicillin clavulanate or a look-a-like and taste-a-like placebo for the next 9 days.

Timeline

Start date
2010-11-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2010-07-21
Last updated
2019-06-10
Results posted
2019-06-10

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01166945. Inclusion in this directory is not an endorsement.